VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AEHRAehr Test Systems
$91.81$2.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAEHRCash Flow

Aehr Test Systems (AEHR) Cash Flow Statement

29Y historyFree accessUpdated daily

Persistent free cash flow deficits, including a -28.4% FCF margin in 2026Q3, highlight a structural challenge in converting revenue into cash during the current industry downturn.

AEHR Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMMay'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97
Cash from Operations-6.82M-7.4M1.76M10.01M1.51M-2.7M-2.02M-5.64M-1.35M-4.5M-6.28M-2.26M-607K-310K-4.88M-4.14M3.25M-11.04M3.62M-1.11M1.5M-2.54M-800K-3.81M-226K1.01M-5.96M342K-664K3M
Operating CF Margin %--12.55%2.65%15.41%2.97%-16.27%-9.08%-26.77%-4.57%-23.79%-43.31%-22.52%-3.08%-1.88%-31.41%-30.15%27.81%-51.55%9.28%-4.05%6.31%-15.81%-5.06%-25.28%-1.8%3.26%-24.31%1.88%-1.63%7.14%
Operating CF Growth %-401.28%-521.41%-82.46%563.86%155.83%-33.45%64.09%-317.25%69.94%28.43%-178.41%-271.66%-95.81%93.64%-17.7%-227.56%129.42%-404.53%426.78%-173.88%159.02%-217.88%79.03%-1588.05%-122.35%116.97%-1841.52%151.51%-122.13%-
Net Income-11.42M-3.91M33.16M14.56M9.45M-2.03M-2.8M-5.24M528K-5.65M-6.79M-6.65M422K-3.42M-3.39M-3.37M-481K-29.97M10.57M2.43M810K-4.87M-3.96M-4.54M-5.27M-141K-2.6M-2.33M2.4M3.3M
Depreciation & Amortization3.67M3.39M1.36M450K307K310K384K431K417K271K203K135K141K322K491K573K690K644K474K323K340K323K384K582K662K651K703K453K479K600K
Stock-Based Compensation6.32M5.16M2.52M03.01M0910K905K996K999K1.02M997K829K601K709K01.73M1.27M000000000000
Deferred Taxes-2.9M-421K-20.77M000000000000004.94M-4.94M000001.61M00-456K-102K-1M
Other Non-Cash Items1.1M584K-130K2.28M-1.7M-1.3M45K-3K-58K201K166K1K-26K0-973K963K360K13.94M990K758K74K226K160K380K15K1.64M33K-140K142K100K
Working Capital Changes-3.6M-12.2M-14.38M-7.28M-9.56M316K-561K-1.74M-3.23M-313K-881K3.26M-1.97M2.19M-1.71M-2.31M945K-1.86M-3.47M-4.62M277K1.78M2.62M-233K2.75M-1.14M-4.09M2.81M-3.59M5M
Change in Receivables312K-3.04M6.79M-3.79M-7.83M-1.37M1.16M-2.04M1.26M-3.51M887K1.77M-720K-206K-1.28M-501K267K-3.61M-4.45M-2.09M-2.02M1.72M00000000
Change in Inventory-27K-2.44M-13.73M-9.47M-6.67M-972K1.16M-112K-2.07M430K70K-1.01M-740K702K-1.11M-1.32M837K5.72M-492K-2.45M-37K849K1.28M-64K1.5M1.09M-1.89M2.74M-1.63M-2.9M
Change in Payables-4.33M-714K-3.89M5.04M1.36M1.88M-1.02M210K-1.09M1.69M564K-850K707K243K570K-353K-446K-1.99M000000000000
Cash from Investing-6.55M-16.07M17.25M-18.66M-416K-227K-163K-173K-572K-477K-919K-118K-289K-127K1.33M-15K-69K-1.11M1.93M-2.49M2.48M3.26M-3.91M4.62M-2.96M1.04M8.55M-1.41M-16.75M-200K
Capital Expenditures-4.75M-4.99M-749K-1.36M-416K-227K-163K-173K-572K-477K-919K-118K-339K-127K-45K-15K-69K-1.11M-1.06M-1.1M-149K-296K-159K-261K-954K-122K-1.36M-755K-315K-600K
CapEx % of Revenue10.5%8.47%1.13%2.1%0.82%1.37%0.73%0.82%1.94%2.52%6.34%1.18%1.72%0.77%0.29%0.11%0.59%5.2%2.7%4.03%0.63%1.84%1.01%1.73%7.59%0.39%5.54%4.16%0.77%1.43%
Acquisitions-1.8M-11.07M000000000050K00000000000000000
Investments------------------------------
Other Investing0000000000000000000-5K-4K-5K416K-87K-19K-787K-274K9K-213K400K
Cash from Financing19.7M625K139K7.32M25.76M1.96M2.17M-5.55M925K21.84M2.51M6.41M391K1.06M1.58M343K176K503K2.34M766K514K247K960K-23K338K301K356K-356K22.86M-2.1M
Debt Issued (Net)0000-1.4M1.4M1.68M-6.11M001.99M2.98M-324K-307K1.41M0000000000-419K-170K306K-4.55M-2.13M
Equity Issued (Net)18.63M625K139K7.32M27.16M560K493K559K925K21.84M512K3.43M715K1.37M168K343K176K503K2.34M766K514K247K960K-23K254K804K526K-662K27.41M-9K
Dividends Paid000000000000000000000000000000
Share Repurchases-1.54M-784K-1.6M-2.06M-429K-20K-10K0000000000000000-182K-141K-468K-136K-1.15M-1K-9K
Other Financing1.07M0000000000000000000000084K-84K0000
Net Change in Cash8.7M-23.93M19.11M-1.43M26.9M-851K5K-11.42M-955K16.86M-4.59M3.72M-515K251K-1.95M-3.75M3.41M-11.29M9.08M-2.84M9.4M4.95M-3.72M877K-2.91M2.07M2.99M-1.41M5.57M-2.1M
Free Cash Flow-11.57M-12.39M1.01M8.65M1.09M-2.93M-2.19M-5.81M-1.92M-4.97M-7.2M-2.37M-946K-437K-4.92M-4.16M3.18M-12.15M2.57M-2.21M1.35M-2.84M-959K-4.08M-1.18M889K-7.31M-413K-979K2.4M
FCF Margin %-25.57%-21.01%1.52%13.31%2.15%-17.64%-9.81%-27.59%-6.51%-26.31%-49.65%-23.7%-4.81%-2.65%-31.7%-30.26%27.22%-56.75%6.58%-8.09%5.68%-17.66%-6.07%-27.01%-9.39%2.86%-29.84%-2.28%-2.4%5.71%
FCF Growth %-89.91%-1330.59%-88.36%692.03%137.3%-33.88%62.36%-202.13%61.32%30.94%-203.29%-150.95%-116.48%91.12%-18.35%-230.81%126.16%-573.09%216.09%-263.61%147.62%-196.04%76.47%-245.42%-232.73%112.16%-1670.7%57.81%-140.79%-
FCF per Share-0.38-0.420.030.300.04-0.12-0.10-0.26-0.08-0.31-0.55-0.20-0.08-0.05-0.55-0.470.37-1.440.30-0.270.18-0.38-0.13-0.57-0.170.12-1.07-0.06-0.140.53
FCF Conversion (FCF/Net Income)1.01x1.89x0.05x0.69x0.16x1.33x0.72x1.08x-2.56x0.80x0.93x0.34x-1.44x0.09x1.44x1.23x-6.75x0.37x0.34x-0.46x1.85x0.52x0.20x0.84x0.04x-7.17x2.29x-0.15x-0.28x0.91x
Interest Paid00015K12K6K000000000000000000000000
Taxes Paid0100K90K21K4K15K000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Customer concentration and EV cyclicality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Quality and Cash Disconnect

According to reported financial data, the relationship between net income and operating cash flow remains highly volatile, with OCF/NI ratios frequently exceeding 1.0 or turning negative, suggesting that accrual-based accounting significantly obscures the underlying cash-generating capacity of the business during this period of operational contraction.

The frequent divergence between net income and operating cash flow indicates that non-cash items and working capital swings are the primary drivers of reported results rather than core operational efficiency. Investors should monitor this disconnect, as it suggests that the company's reported earnings may not be a reliable proxy for its actual ability to fund operations internally.

Persistent Free Cash Flow Deficits

As evidenced by the trailing ten-quarter data, AEHR has struggled to maintain positive free cash flow, with FCF margins reaching as low as -46.0% in 2025Q2, highlighting a structural inability to cover capital requirements through internal operations during the current industry-wide semiconductor equipment downturn.

The consistent negative FCF trajectory suggests that the company's capital-intensive business model is currently outstripping its ability to generate cash from sales. This trend warrants investigation into whether the current level of R&D and infrastructure spending is sustainable without further external financing or a significant rebound in system-level demand.

Working Capital Volatility Pressures Liquidity

Based on the provided cash flow statements, working capital changes have frequently acted as a significant drag on cash, with a notable $6.6M outflow in 2025Q2, indicating that the company's cash cycle is highly sensitive to the timing of customer acceptances and inventory management.

The erratic nature of working capital suggests that the company is struggling to manage its cash conversion cycle effectively amidst lumpy revenue recognition. This volatility may indicate that inventory is building up faster than it can be converted into cash, potentially signaling a mismatch between production schedules and actual customer demand.

Capital Allocation Amidst Cash Burn

Data from recent filings shows that despite persistent operating losses, the company has continued to allocate cash toward share repurchases, with $454,000 utilized in 2026Q3, a decision that appears counterintuitive given the current need to preserve liquidity during a period of negative cash flow.

The decision to prioritize share buybacks while the core business is burning cash may suggest a management focus on supporting the stock price rather than prioritizing balance sheet resilience. Investors should monitor whether this capital allocation strategy remains viable if the current negative cash flow trend continues into future quarters.

AEHR — Frequently Asked Questions

Quick answers to the most common questions about buying AEHR stock.

How much cash does Aehr Test Systems (AEHR) generate from operations?

Aehr Test Systems (AEHR) generated $-7.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Aehr Test Systems's free cash flow?

Aehr Test Systems (AEHR) reported negative free cash flow of $12.4M in 2025, indicating capital requirements exceeded cash from operations.

What is Aehr Test Systems's capital expenditure (CapEx)?

Aehr Test Systems (AEHR) spent $5.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Aehr Test Systems distribute cash to shareholders?

In 2025, Aehr Test Systems (AEHR) spent $0.8M on share repurchases. This shows the company's commitment to returning capital to its equity investors.